Scientific Symposium on Advanced Therapy Medicinal Products - ‘Contribution, evolution, revolution’
EventHumanAdvanced therapies
- The original event time is:
- Thursday, October 10, 2024 - 09:00 - 17:00 Amsterdam time (CEST)
Date
- , -
Location
- European Medicines Agency, Amsterdam, the Netherlands
Event summary
On 30 December 2008, the Regulation (Regulation (EC) No 1394/2007) on advanced therapy medical products (ATMP) came into operation. As a result, in January 2009, the Committee for Advanced Therapies (CAT) held its inaugural meeting.
15 years later, ATMPs have become established: 27 gene- and cell / tissue-based medicines are offering treatment options for unmet medical needs.
This symposium will showcase how the work of CAT has contributed to the regulatory framework for ATMPs in Europe and to the approval of these innovative products.
It will also outline the evolution of CAT and its adaptation to the challenges posed by novel classes of ATMPs.
The ultimate objective is to ensure that high quality, safe and efficacious products become new treatment options.
Many more novel developments are on the horizon. Each has the possibility to revolutionise patient care, and their own merits and challenges.
Speakers and audience will discuss the vision for ATMPs for the next 15 years.
Audience will include:
- CAT members
- EMA committees and working party members
- Members of regulatory authorities
- Representatives from industry and academia
- Representatives of patients and doctors
- Policymakers
- Members from the public interested in ATMPs and the work of CAT
Video recording
Registration
The symposium is held on Thursday, 10 October 2024, at the headquarters of the European Medicines Agency in Amsterdam, the Netherlands.
Participants can also join remotely.
You can register your interest to attend the symposium either in-person or remotely.
The deadline for registration for in-person attendance is 24 September 2024:
The deadline for registration for remote attendance is 1 October 2024:
We will confirm your participation shortly after the relevant deadline.
We will accept two nominations per organisation to attend in person. This will ensure a wide representation in the symposium. More representatives can join remotely.
As there are limited seats available, we will consider your registration for in-person attendance as a firm commitment to attend.
In case this is needed, you should submit your cancellation of in-person attendance no later than 1 October. This will allow other participants to join.
A contribution of 18 Euro will be collected upon arrival from the in-person participants for lunch and refreshments.
Let us know in what capacity would you be attending. This can be as:
- Academia - hospital
- Industry
- Industry - SME
- Healthcare professional
- Patient - patient representative
- Health technology assessment body (HTA)
- Regulatory authority
- Other